期刊文献+

3.0 T磁共振灌注加权成像在脑星形细胞瘤分级诊断中的价值 被引量:4

The Value of MR Perfusion Weighted Imaging in Grading Astrocytoma
原文传递
导出
摘要 目的探讨对比剂首过MR灌注加权成像(perfusion weighted imaging,PWI)在脑高、低级别星形细胞瘤鉴别诊断中的价值。资料与方法分析40例经手术病理证实的星形细胞瘤患者的MRI资料,所有患者术前均行常规MRI平扫+增强、PWI,其中低级别组(WHO I、II级)14例,高级别组(WHO III、IV级)26例。结果常规MR平扫+增强扫描诊断高级别星形细胞瘤的敏感性为69.2%,特异性为64.3%,阳性预测值为78.3%,阴性预测值为52.9%,准确性为67.5%。高、低级别星形细胞瘤瘤体实质相对脑血容量(rCBV)值和相对脑血流量(rCBF)值差异均有统计学意义(P<0.05),而相对平均通过时间(rMTT)值差异无统计学意义(P>0.05)。选择Youden指数最大值作为高、低级别星形细胞瘤最佳诊断临界点时,瘤体实质rCBV值受试者工作特征(ROC)曲线下面积(AUC)为0.961,阈值为2.71,敏感性为85.0%,特异性为100%,阳性预测值为100%,阴性预测值为78.0%;瘤体实质rCBF值ROC曲线的AUC为0.877,阈值为1.45,敏感性为85.0%,特异性为71.0%,阳性预测值为85.0%,阴性预测值为71.0%。结论与常规MRI比较,对比剂首过PWI能提高术前星形细胞瘤分级诊断的准确性。瘤体实质rCBV值是星形细胞瘤分级诊断的最特异性指标。 Objective To evaluate the grading value of MR perfusion weighted imaging(PWI)in astrocytoma.Materials and Methods Forty patients with primary cerebral astrocytoma confirmed by pathology underwent conventional MR imaging,dynamic contrast-enhanced T2-weighted perfusion MR imaging on a Siemens 3.0T scanner.Fourteen tumors were low-grade(I-II)and 26 were high-grade(III-IV).Results Sensitivity,specificity,PPV,NPV and accuracy of conventional MR were 69.2%,64.3%,78.3%,52.9% and 67.5%,respectively,in determining high-grade astrocytoma.Significant statistical differences were found in the rCBV and rCBF about the core of tumor between low and high grade astrocytoma respectively(P0.05),but the rMTT had no significant statistical differences(P0.05).The maximum youden index was chosen to determine the optimum thresholds of all the parameters in ROC analyses.At threshold value of 2.71 for rCBV in the core of tumor,the sensitivity,specificity,PPV,and NPV for diagnosing high grade astrocytoma were 85.0%,100%,100%,and 78.0%.In the same way,at threshold value of 1.45,the sensitivity,specificity,PPV,and NPV were 85.0%,71.0%,85.0%,and 71.0%.Conclusion DSC PWI increases the accuracy of pre-operative imaging grading of astrocytoma for the conventional MR imaging.The rCBV in the core of tumor is the most superior diagnostic performance.
出处 《临床放射学杂志》 CSCD 北大核心 2010年第12期1608-1612,共5页 Journal of Clinical Radiology
关键词 星形细胞瘤 灌注加权成像 受试者工作特征曲线 Astrocytoma Perfusion weighted imaging Receiver operating characteristic curve
  • 相关文献

参考文献13

  • 1Law M, Yang S, Babb iS, et al. Comparison of cerehral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced peffusion MR imaging with glioma grade. Am J Neuroradiol, 2004,25 : 746.
  • 2Cha S, Knopp EA, Johnson G, et al. Intracranial mass lesions: dynamic contrast-enhanced susceptibillty-weighted echoplanar perfusion MR imaging. Radiology ,2002,223 : 11.
  • 3Watanabe M,Tanaka R,Takeda N. Magnetic resonance imaging and histopathology of cerebral gliomas, Neuroradiology 1992,34:463.
  • 4Moller-Hartmann W, Herminghaus S, Krings T, et al. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology ,2002,44 : 371.
  • 5Batra A,Tripathi RP, Singh AK. Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging. Australas Radiol, 2004,48 : 324.
  • 6Maia AC, Malheiros SM,da Rocha AJ,et al. MR cerebral blood volume maps correlated with vascular endothelial growth factor expression and tumor grade in nonenhancing gliomas. Am J Neuroradiol, 2005,26:777.
  • 7Sun J, Jae H, Young M, et al. Perfusion MR imaging in gliomas: Comparison with histologic tumor grade. Korean J Radiol,2001,2 : 1.
  • 8Burger PC. Malignant astrocytoma neoplasma:classifieation pathology anatomy and response to therapy. Semin Oncal, 1986,13:16.
  • 9Knopp EA, Cha S, Johnson G, et al. Glial neoplasms : dynamic con- trast-enhanced T2 *-weighted MR imaging. Radiology, 1999, 211: 791.
  • 10Petrella JR,Provenale JM. MR perfusion imaging of the brain:techniques and applications. AJR ,2000,175:207.

二级参考文献27

  • 1[1]Jezzard P. Advances in perfusion MR imaging. Radiology, 1998, 208:296
  • 2[2]Zagzag D, Friedlander DR, Dosik J, et al. Tenascin-C expression in angiogenic vessels of human astrocytomas and by human endothelial cells in vitro. Cancer Res, 1996, 56:182
  • 3[3]Kolles H, Niedermayer I, Feiden W. Grading of astrocytomas and oligodendrogliomas. Pathology, 1998, 19:259
  • 4[4]Aronen HJ, Gazit IE, Luis DN, et al. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings.Radiology, 1994, 191:41
  • 5[5]Sugahara T, Korogi Y, Kochi M,et al. Correlation of MR imaging determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas. AJR, 1998, 171:1479
  • 6[6]Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology, 1999, 211:791
  • 7[7]Lam WW, Chan KW, Wong WL, et al. Pre-operative grading of intracranial glioma. Acta Radiol, 2001, 42:.548
  • 8[8]Ludemann L, Grieger W, Wurm R, et al. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol, 2001, 11:1231
  • 9[9]Baba Y, Yamashita Y, Onomichi M, et al. Dynamic magnetic resonance imaging of head and neck lesions. Top Magn Reson Imaging, 1999, 10:125
  • 10[10]Suzuki A, Mineura K, Sasajima J,et al. Sequential analysis of the integrated images of PET, CT and MR in malignant brain tumors before and after radiotherapy. No to Shinkei (Japanese), 1996, 48:449

共引文献8

同被引文献34

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部